Your session is about to expire
← Back to Search
Sodium-Glucose Cotransporter-2 Inhibitor
Treatment A for Type 1 Diabetes
Phase 1 & 2
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Men and women between the ages of 18 and 65 years old, inclusive, at the time of screening;
Females of non-child bearing potential must be ≥ 1 year post-menopausal or documented as being surgically sterile. Females of child bearing potential must agree to use two methods of contraception during the entire study and for an additional 3 months after the end of dosing with the investigational product;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-weeks
Awards & highlights
Study Summary
This trial is testing a new diabetes treatment that could improve blood sugar levels.
Eligible Conditions
- Type 1 Diabetes
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Beta-hydroxybutyrate (BHB) Level
Change in Glycemic Control
Change in Vascular Endothelial Function
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Treatment AActive Control2 Interventions
Daily, Oral,10mg dapagliflozin in combination with Weekly, Subcutaneous, 35mg in 1mL solution REMD-477
Group II: Treatment BPlacebo Group2 Interventions
Daily, Oral,10mg dapagliflozin in combination with Weekly, Subcutaneous, 1mL solution Placebo
Find a Location
Who is running the clinical trial?
JDRFUNKNOWN
3 Previous Clinical Trials
50,053 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,114 Previous Clinical Trials
1,519,868 Total Patients Enrolled
REMD Biotherapeutics, Inc.Industry Sponsor
6 Previous Clinical Trials
308 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger